Abstract: Embryonic stem (ES) cells may offer an unlimited cell source for the treatment of diabetes. However, a successful derivation of ES cells into islet-cells has proven to be more difficult than it was initially expected. Considering that the pancreas coordinates the global use of energy in the organism by secreting digestive enzymes and hormones, it is understandable that a sophisticated and tight regulation that lies on the pancreas itself to orchestrate its own tissue development and maturation. The complex process of endocrine cell differentiation can be better understood by analyzing the normal development of the pancreas. The proper detection of the signals provided in the pancreatic environment gives us a clue as to how the stem cells give rise to the whole pancreas. Careful and extensive screening of the natural or synthetic cytokines and growth factors and biochemical compounds that are essential in pancreatic development is required to properly mimic the process in vitro. Such a study would allow the researchers to achieve selective control of the differentiation and proliferation of the stem cells.
INTRODUCTION
development. Finally, this study may contribute to the development of new approaches for ES cell differentiation toward the β-cell phenotype. Clinical islet transplantation has been a very promising cure for diabetes mellitus, thus allowing patients to become insulinindependent using a glucocorticoid-free immunosuppressive regimen. However, given the current global donor shortage, the widespread use of islet transplantation has been seriously restricted [1, 2] . The generation of insulin-producing cells derived from embryonic stem (ES) cells could constitute a potential alternative source to the cadaveric-derived pancreatic islets for the treatment of diabetes. ES cells can be unlimitedly propagated in vitro while maintaining their undifferentiated state. ES cells are also able to closely mimic the natural development in vitro of forming spherical aggregates, the socalled embryoid bodies (EB). EB formation can itself derivate tissues of three germinal layers [3] . This early observation in EB has been widely used to differentiate islet cells. In addition, in order to remove the undesired cells and enrich the pancreatic committed cells population Insulin-Transferrin-sodium Selenium (ITS) selection has been widely utilized. The remaining cells are stimulated to grow and recover using growth factors such as epithelial growth factor (EGF) and fibroblast growth factor-2, (FGF-2) [4] [5] [6] [7] . Eventually, such resulting cells after the intake of insulin can be artificially identified as insulin-secreting cells. However, these cells are actually incapable of synthesizing insulin de novo [6, 7] . These premature results have indicated that the difficulty in differentiating bona-fide the ES cells is greater than was that expected. Meanwhile, the natural development of the pancreas, which is tightly regulated by the local and neighboring stimuli, is poorly understood. We will herein mainly focus on the major steps of pancreatic development, which may contribute to a better understanding of the main factors involved in the β-cell differentiation process. Moreover, we will discuss the role of the major transcriptional factors, which drive the pancreatic islet
ENDODERM FORMATION
ES cells are derived from the inner cell mass of the blastocyst; such ES cells are in fact a group of the undifferentiated cells localized in the epiblast. The epiblastderived cells in vivo give rise to the three principal germ layers through a process called gastrulation, and thus their terminally differentiated tissues [3, 8] . The initiation of gastrulation is recognized by the formation of the primitive streak (PS) at the posterior part of the epiblast. Then, within the PS, the mesendoderm cells regulate the expression of several genes, such as goosecoid (GSC) forkhead box A2, (Foxa 2), chemokine C-X-C motif receptor 4 cxcr4, sex determining region-Y box 17 (Sox17α/β), brachyury, E-cadherin, vascular endothelial growth factor receptor-2, (VEGFR2), VE-cadherin, platelet-derived growth factor receptor-α (PDGFRα), and GATA binding protein 4, (GATA-4) for the cell-fate differentiation of the definitive endoderm and mesoderm progenitors. The endoderm has two main populations, namely the visceral and the definitive endoderm. The visceral endoderm is derived from the PS overlaying cells, which are eventually displaced to integrate with the extra-embryonic yolk sac related tissues [8, 9] . Such visceral yolk sacs can early and highly express α-fetoprotein, (AFP), albumin, insulin-II, and in a lower rate insulin-I too, but they lack Neurogenin-3 (Ngn3), Islet-1 (Isl-1), Neuro D/β2, and glucagon [10, 11] . Moreover, insulin-I, Neuro D/β2, and Isl-1 are expressed in both the endocrine cells and the neurons, but Ngn-3 and glucagon are exclusive to the endocrine-developing pancreas [12] . Therefore, insulin-, AFP-or albumin-analyses would not be appropriate. Contribution of the visceral yolk sacderived cells and neurons can also overestimate the differentiated populations. In contrast, the definitive endoderm is only derived from within the PS, and mostly from the anterior part ( Fig. 1) [8, 9] . Recently, researchers have clearly demonstrated in a comprehensive study the in vitro differentiation of both human and mouse ES cells into the The left panel shows the normal distribution of the three germinal layers post-gastrulation and their relations, which determine the tissue-specific differentiation. The right panel shows how the definitive endoderm is responsible for deriving the entire gastrointestinal tract and lungs; in particular the portion subjacent to the notochord is capable of originating pancreatic tissue.
definitive endoderm with a high efficiency using Activin A and a low serum concentration. Their analyses clearly indicate the possibility to modulate in vitro a direct differentiation of the ES cells instead of the EB formation [9, 13] . The definitive endoderm cells are the only cells that can truly originate the gastrointestinal tract, including the pancreas and liver [9] . Researchers have found that the differentiation protocols based on EB formation can render less than 1% of the differentiated β-like cells. However, upon stimulation with Activin βB, Exendin-4, and nicotinamide, they may increase up to 2.73% [11] . Considering these results and the fact that the islet cells represent less than 2% of the total pancreatic tissue, different approaches are required.
DEVELOPMENT OF THE PRIMITIVE PANCREAS
Once committed, definitive endoderm cells align along the vertical body axis to form the gut tube, which is then divided into the foregut, midgut and hindgut. The dorsal primitive pancreas is derived from the dorsal endoderm of the foregut and midgut, along with the dorsal part of the esophagus, stomach, and duodenum ( Fig. 1) . Initially, the dorsal endoderm and the notochord are united while flaked in the counterpart by the cardiogenic primordium until the dorsal aorta fuse (on E9.5 in mice), which separates the endoderm from the notochord. These extracellular signals from the neighboring cells result in the expression of the tissue-and cell type-specific transcriptional Fig. (2) . Tissue-specific differentiation of the primitive pancreas.
A schematic representation shows the extracellular signals from the neighboring tissues, which regulate the tissue-and cell type-specific differentiation.
factors of the pancreas [8, 14, 15] . The deletion of the notochord in cultured chick embryos results in the loss of the dorsal pancreatic gene expression. Moreover, the co-culture of the notochord with the endoderm fates to become pancreas restoring the expression of pancreatic genes. This important observation clarified the role of the focal sonic hedgehog (shh) inhibition and regulation of Pancreas-duodenum homeobox 1 (pdx-1) by activin and FGF-2 along the fore/midgut, thus resulting in three different derived tissues, namely stomach (shh-positive, pdx-1-negative), pancreas (shh-negative, pdx-1-positive), and duodenum (shh-positive, pdx-1-positive) (Fig. 2) [8] . These results indicate the key role of the anatomically related tissues in the proper pancreatic development. The dominant and localized expression of pdx-1 and hlxb9 (homeobox transcription factor), while shh is repressed along the fore/midgut derived tissues, is one of the main characteristics of the primitive pancreas [8, 12, 14, 16] . differentiation occurs in a very peculiar manner. Within the primitive acinar aggregates, only the central cells became Ngn-3 expressing endocrine progenitors. Those Ngn-3 expressing endocrine progenitors will eventually be surrounded by exocrine cell progenitors in a process called lateral inhibition. Several parts of this lateral inhibition process remain unknown, but new evidence points to the key roles that the mesenchyma and the extracellular matrices play in the process, such as growth differentiation factor 11 (GDF11) and laminin-1 (Fig. 3 ) [19] [20] [21] [22] [23] [24] . The capacity of further proliferation of such progenitor cells is mainly driven by fibroblast growth factors (FGFs) [25] [26] [27] . The surrounding mesenchyme regulates the timing and growth factors for the proper pancreatic development in both the exocrine and endocrine cell progenitors [28] . The expression of Isl-1 within the mesenchyme of the primitive pancreas regulates the transitional differentiation of the primitive pancreatic epithelium to the endocrine cells, increasing the endocrine population [29] . Moreover, the endocrine cell population can also be enriched from a subset of hepatocyte nuclear factor 1-β (HNF1β) expressing cells, which transiently express Ngn-3 [30, 31] . The Ngn-3 expressing cells can rapidly proliferate as common endocrine progenitors, while differentiated α-, β-, and δ-cells cannot, once they commit to their final lineage during the development of the pancreas [18, 21, 32] . Later, during the terminal fetal growth [18, 21] and the postnatal period, the differentiated endocrine cells are able to reenter into the cell cycle [33, 34] . It is clear that the Ngn-3 positive cells play a major role in the embryonic development of the pancreas, giving rise to the whole pancreatic endocrine lineages. Nevertheless, their contribution to the balance of adult tissue remains unclear. Recent evidence has indicated that their population dramatically declines at birth and becomes undetectable in adult tissues even during pancreatic regeneration after surgical injury [20, 35] .
PANCREATIC ENDOCRINE CELL-FATE DIFFERENTIATION
Although, most of the stimulation of the primitive pancreas is mainly directed toward its dorsal part, it has also a great influence over the ventral segment. Particularly, the common pancreatic phenotype (pdx-1+, hlxb9+ and shh-) will be equally adopted after both the dorsal and ventral parts merge [8, 12] . Briefly, a new transitional change may take place, which will initiate the derivation of the two cell populations later recognized in the adult tissues as the endocrine-and exocrinederived cells. The regulation of the cell-fate differentiation process involves the expression of the several of the wellcoordinated transcriptional factors and signals, known as the Delta-Notch signaling system (Fig. 3) [12, [16] [17] [18] . Both exocrine and endocrine may transiently retain, at least in part, the common pancreatic phenotype, but then differentiate and commit to the exocrine progenitor expressing both the pancreas specific transcription factor 1a (Ptf1a-p48) and the hairy and enhancer of the split homolog (Hes1). Hes1 is actually a transient repressor which allows the exocrine cell progenitors to proliferate partially undifferentiated, while their progeny will only express Ptf1a-p48 [12, 17, 18] . In contrast, the early endocrine progenitors will express initially Ngn-3 and later coexpress Beta2/Neuro D and others upon commitment to each specific-endocrine lineage. In vivo endocrine cell-fate
ENDOCRINE LINEAGE SPECIFIC-DIFFERENTIATION AND MATURATION
The development of the pancreas requires the orchestration of several specific transcriptional and growth factors. Many studies have been conducted to determine the interactions between the pancreatic epithelium and the mesenchyma to terminally differentiate the hormone-secreting cells [18, 29, 36] . Some investigators have reported that glucagon is the first Fig. (3) . Endocrine cell-fate differentiation of the developing pancreas.
A schematic draw shows the regulation of the cell-fate differentiation of the early pancreas-committed stem cells (pdx-1+, hlxb9+ and shh-) into endocrine precursors (Ngn3+) by cell-cell Delta-Notch signaling while the neighbor cells are repressed (pdx-1+, Hes1+, and Ngn3-) by a process called lateral inhibition.
peptide hormone to be detected in the developing pancreas [36, 37] . occurrence of diabetes [39] . The β-cells derived from the adult pancreas have a glucose-induced insulin secretion and a comparatively higher amount of insulin secretion, whereas the fetal and neonatal islets are not yet glucose-responsiveness [38] . Both the fetal and neonatal insulin-expressing cells achieve glucose-responsiveness after they show the high expression of glucose transporter 2 (Glut2). However, Glut2 is expressed either in MafA+, Nkx6.1+, and pdx-1+ (young β-cells), or MafB+, Nkx6.1+, or pdx-1+ cells (fetal β-cells). This observation suggests that the switch from MafB to MafA may not be necessary in order to initiate the Glut2 expression but it meaningfully contributes to the β-cell replication and maturation [38] . Therefore, the low Glut2 expression may be considered as a cell marker of the β-cell specific precursors rather than the mature β-cells. After birth, the rapid proliferation of β-cells is mainly driven by cyclin D2 and Ki67 and β-cells improve their capacity to secrete insulin in order to properly control the increasing metabolic demands [33, 34] .
The use of antisense oligonucleotides against preproglucagon in the developing pancreas on E11-13 grown in tissue culture resulted in the marked inhibition of insulin gene expression. In contrast, a developing pancreas on E15 grown under the same conditions without antisense showed a normal level and pattern of insulin gene expression [36] . These observations strongly suggest the interactions of the earlydifferentiated glucagon-expressing cells on the terminal differentiation of the β-cells. Despite the co-existence of both α-and β-cells in the adult pancreas, the cells have antagonistic roles against each other. Both α-and β-cells are derived from a common progenitor, Ngn3-expressing cells, during the development of the pancreas. β-cells express insulin and MafA at a 250-fold higher rate than α-cells. In contrast, α-cells expressed glucagon and MafB at a 450-fold higher rate than β-cells. In addition, researchers have found new evidence that the expression of MafB precedes that of MafA during β-cell differentiation in the pancreas and that the differential expression of NK6 transcription factor related locus 1 (Nkx6.1) in MafB+ cells defines whether the cells express insulin or glucagon. The appearance of Nkx6.1 expression and the increased expression of pdx-1 is critical for the terminal differentiation of β-cells at this last stage. Particularly, at this point the co-expression of Nkx6.1 with the high re-expression of pdx-1 drives the insulin gene expression in the young β-cells. The expression of MafA is involved in the process of both fetal and post-natal β-cell replication and maturation (Fig. 4 ) [38] . The loss of MafA expression maintains the normal pancreatic morphology at birth, but after birth it reduces the proportion of β-cells with an impaired glucose tolerance and the protocol in human ES cells, which allows for the in vitro derivation of the cells existing in the posterior foregut from the definitive endoderm committed cells using cyclopamine, retinoic acid (RA) and fibroblast growth factor-10 (FGF-10) [43] . Cyclopamine is well recognized as one of the most potent shh inhibitors, but it also exhibits a teratogenic adverse effect [44] . This protocol generates pancreatic islet-like cells capable of expressing the main hormones insulin, glucagon, and somatostatin. However, the lack of controlled generation of the endocrine progenitor, Ngn-3-expressing cells, in their protocol have limited the large production of pancreatic endocrine cells. Moreover, the finally generated, ES-derived β-cells retain a fetal phenotype by expressing only MafB and not MafA, and thus lack a glucose-sensitive insulin secreting capacity [43] . The next step should be to address how to generate Ngn-3-expressing cells in vitro for the large production of pancreatic endocrine cells, and then to explore a method to maturate such cells to β-cells with an adult phenotype. 
CURRENT STATUS OF DIFFERENTIATION OF HUMAN ES CELLS TO ISLET-LIKE CELLS

CONCLUSIONS AND FUTURE PERSPECTIVES
and Glut2 = glucose transporter 2 REFERENCES The insulin-producing cells generated from ES cells represent an attractive alternative source to the cadaveric isolated pancreatic islets for the treatment of diabetes. However, the efficient differentiation of ES cells into β-like-cells still remains a big challenge. The lack of success in the early attempts has revealed the importance of a better understanding of the fundamental normal development of the pancreas. Considering that the pancreas is exclusively derived from the definitive endoderm and that the endocrine cell population represents a minority, a successful β-cell differentiation would require a high definitive endoderm commitment rather than a visceral endoderm, or ectoderm, which arises from aberrant differentiated cells with a most likely incomplete expression of the β-cell markers and lack of function [45] .
